Drinking more coffee could reduce liver cancer risk, suggests study
Drinking more coffee could reduce the risk of developing the most common form of primary liver cancer, according to a study led by the University of Southampton.
May 29, 2017
1
978
Drinking more coffee could reduce the risk of developing the most common form of primary liver cancer, according to a study led by the University of Southampton.
May 29, 2017
1
978
Researchers at University of California San Diego School of Medicine, with collaborators across the nation, have determined that magnetic resonance elastography (MRE) can be an accurate, non-invasive tool to identify liver ...
May 11, 2017
0
1
Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants. ...
May 6, 2017
0
0
An international study based at UT Southwestern Medical Center revealed a striking genetic-environmental interaction: Obesity significantly amplifies the effects of three gene variants that increase risk of nonalcoholic fatty ...
Apr 26, 2017
0
17
Nonalcoholic fatty liver disease, a condition where fat builds up in the liver, is now the most common chronic liver disease diagnosed in adults and children. Although the disease is linked with obesity, scientists don't ...
Apr 24, 2017
0
0
Results from the ANSWER study presented today showed that long-term administration of human albumin improves the survival rate of patients with decompensated cirrhosis (the symptomatic stage of chronic liver disease). The ...
Apr 22, 2017
0
5
The results of the BEZURSO study, presented today, found that bezafibrate in combination with UDCA normalised prognostic markers of liver disease in patients with primary biliary cholangitis (PBC) with an inadequate response ...
Apr 22, 2017
0
44
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.
Apr 21, 2017
0
3
Analysis of patient outcome data from the POLARIS-1, 2, 3 and 4 studies presented today demonstrate that patients with Hepatitis C virus (HCV) and cirrhosis experience the greatest improvement of patient-reported outcome ...
Apr 20, 2017
0
0
Data presented today demonstrate that there are considerable restrictions in the reimbursement of direct-acting antiviral (DAA) therapy across European countries, particularly with respect to the severity of liver fibrosis ...
Apr 20, 2017
0
3